Melanoma Risk and Survival among Organ Transplant Recipients Hilary A. Robbins, Christina A. Clarke, Sarah T. Arron, Zaria Tatalovich, Amy R. Kahn, Brenda Y. Hernandez, Lisa Paddock, Elizabeth L. Yanik, Charles F. Lynch, Bertram L. Kasiske, Jon Snyder, Eric A. Engels  Journal of Investigative Dermatology  Volume 135, Issue 11, Pages 2657-2665 (November 2015) DOI: 10.1038/jid.2015.312 Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Standardized incidence ratios comparing melanoma incidence in 139,991 non-Hispanic white transplant recipients with the general population, stratified by time since transplantation and melanoma stage. Journal of Investigative Dermatology 2015 135, 2657-2665DOI: (10.1038/jid.2015.312) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 Melanoma-specific mortality after invasive melanoma for transplant recipients compared with non-recipients. Comparisons are shown overall (a) and by stage of melanoma: localized (b), regional (c), and distant (d). Journal of Investigative Dermatology 2015 135, 2657-2665DOI: (10.1038/jid.2015.312) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions